TNL Mediagene filed a Form 6-K with the SEC on October 30, 2026, reporting the completion of its sale of the Japan Holding Company and its subsidiaries to MI Company Inc. for aggregate consideration of $5.5 million.

Key Highlights

  • Sale closed October 30, 2026: TNL Mediagene completed the Japan Business Sale to MI Company Inc., an acquisition vehicle led by Motoko Imada, the Company's former Chief Executive Officer.
  • Total consideration of $5.5 million: Payment consisted of approximately $3.85 million in cash, approximately $0.15 million via set-off of net intercompany debt liabilities, and $1.5 million through assumption or extinguishment of certain promissory note indebtedness.
  • Price adjustment mechanism: The $5.5 million consideration is subject to adjustment based on changes in net intercompany debt liabilities from a reference amount of $612,064 as of July 31, 2026, with the combined adjustment and set-off capped at $500,000.
  • Multiple executive departures: Effective October 30, 2026, Motoko Imada and Hiroto Kobayashi resigned from the Board, and Motoko Imada, Hiroyuki Terao, and Aya Miyake resigned as CEO, CFO, and Chief Governance Officer, respectively.
  • Nasdaq compliance addressed: The Company disclosed that, as of the filing date, it believes its stockholders' equity exceeds the minimum $2.5 million requirement under Nasdaq Listing Rule 5550(b)(1).
  • Taiwan operations continue: According to the filing, following the sale, the Company continues to own and operate its business in Taiwan.

TNL Mediagene Divests Japanese Operations, Addresses Nasdaq Equity Requirement

According to the Form 6-K furnished for the month of October 2026 (Commission File Number 001-42424), TNL Mediagene completed the sale of TNL Mediagene Inc., its wholly owned Japanese holding company, to MI Company Inc. on October 30, 2026. The Japan Holding Company owned, directly or indirectly, all issued and outstanding shares of Mediagene Inc. and Infobahn Inc. The filing notes that MI Company is a Japanese joint-stock company formed as the acquisition vehicle for an investor group led by Motoko Imada, who served as the Company's CEO and a board member until the transaction closed.

The filing states that the Japan Business Sale was "reviewed, evaluated and negotiated by a special committee of the Board comprised solely of disinterested and independent directors" and was approved by the Board acting on that committee's recommendation. At closing, the Special Committee confirmed that its recommendation, the fairness opinion of Imperial Capital, LLC, and the Company's corporate approvals "remained in full force and effect." The aggregate consideration of $5.5 million was satisfied in full at closing through the three components described above.

In connection with the transaction, the filing reports that five individuals departed their roles effective October 30, 2026. The filing specifies that the Board resignations of Ms. Imada and Mr. Kobayashi "were not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices." Separately, the Company disclosed its belief that the transaction has brought its stockholders' equity above the $2.5 million minimum threshold required by Nasdaq Listing Rule 5550(b)(1), according to the filing. TNL Mediagene's stock is listed on NASDAQ:TNMG.

What Was Disclosed

TNL Mediagene disclosed the October 30, 2026 completion of its Japan Business Sale for $5.5 million in aggregate consideration, the resignation of five executives and directors, and its belief that it has regained compliance with the Nasdaq minimum stockholders' equity requirement.